News-Medical.Net Gene Therapy News
-
WVU RNI expands pioneering treatment for Alzheimer’s to open the blood-brain barrier
Aug 6, 2020 | 21:21 pmA hospital nurse for 33 years, Nanette Miller would call her husband Frank at the end of each shift to let him know she was coming home. On Dec. 7, 2018, the phone call came with a somber declaration: "I can't do this anymore."
Read more... -
NCI gives 'exceptional' rating to Penn's Abramson Cancer Center
Aug 5, 2020 | 03:57 amThe National Cancer Institute has once again rated the Abramson Cancer Center of the University of Pennsylvania as "exceptional," the highest possible rating for an NCI-designated comprehensive cancer center.
Read more... -
Penn researchers identify genetic driver of Charcot-Marie-Tooth disease
Aug 4, 2020 | 02:20 amInherited mutations in a gene that keeps nerve cells intact was shown, for the first time, to be a driver of a neuropathy known as Charcot-Marie-Tooth (CMT) disease.
Read more... -
Thermo Fisher Scientific launches industry-leading, cGMP-compatible CTS Series Laboratory Equipment
Jul 30, 2020 | 08:54 amThermo Fisher Scientific announces the launch of an industry-leading product, compliance and services portfolio, compatible with current Good Manufacturing Practice and designed to enable rapid start-up of clinical and commercial cell and gene therapy manufacturing.
Read more... -
Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy
Jul 29, 2020 | 09:18 amAvacta Group plc, is pleased to announce an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co.Ltd and AffyXell Therapeutics.
Read more... -
DSI to conduct digital partnering meetings during BIO International Convention
Jul 29, 2020 | 08:46 amDesign Space InPharmatics, a Regulatory Drug Development Consulting Firm provides Chemistry, Manufacturing and Controls regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and and gene therapy products.
Read more... -
COVID-19 DSI operation update
Jul 29, 2020 | 08:39 amWe are truly living in a new age of communication, between video conferences and virtual work meetings, to live recorded strategy and operational discussions, we are all doing our best to stay in touch and stay distant at the same time.
Read more... -
Novel research determines the prevalence of chronic kidney disease
Jul 24, 2020 | 07:41 amA new study looking at nearly three decades of data from some 54,000 people has determined that the overall prevalence of chronic kidney disease (CKD) for several racial/ethnic and socioeconomic groups in the United States has stabilized in recent years, except Mexican Americans.
Read more... -
New strategy allows long-term, non-invasive tracking of cardiomyocytes
Jul 23, 2020 | 15:59 pmA new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart.
Read more... -
Eikonoklastes Therapeutics announces closing of oversubscribed seed financing
Jul 23, 2020 | 08:45 amEikonoklastes Therapeutics, a preclinical stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases with unmet clinical need, today announced closing of an oversubscribed seed financing.
Read more...